| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.082 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |